Search results
Results from the WOW.Com Content Network
This page was last edited on 16 December 2024, at 00:06 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
2021: In March, the company announced it would acquire Five Prime Therapeutics and its lead candidate, bemarituzumab, for $1.9 billion. [93] [94] [95] In the same month, Amgen acquired Rodeo Therapeutics for $720 million. [96] [97] The FDA approved Amgen's Lumakras in May for treatment of patients with KRAS-G12C-mutated non-small cell lung ...
This file contains additional information, probably added from the digital camera or scanner used to create or digitize it. If the file has been modified from its original state, some details may not fully reflect the modified file.
For premium support please call: 800-290-4726 more ways to reach us
He also co-founded the San Diego Regional Cancer Center, of which he was president and CEO 1990 until 2000. Renamed the Sidney Kimmel Cancer Center in 1995, it filed for chapter 11 bankruptcy in 2009. [19] More than 50 San Diego companies trace their lineage directly to Hybritech, its founders and early employees.
Prime operates 44 acute care hospitals in 14 states. [12] The hospital network has over 45,000 employees and physicians and more than 8,700 patient beds. [2] Prime Healthcare’s national corporate headquarters is located in Ontario, California. [12]
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. [2]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!